Let's Get Started

Year: 2017

(OTCMKTS:BTCS) BTCS Inc. & Blockchain

Jun 19, 2017

Introduction

BTCS Inc. ( BTCS ) is an early adopting online e-commerce marketplace where   merchandise is available for direct retail purchase using digital cryptocurrencies, such as bitcoin, litecoin, and dogecoin. The company name is an acronym of sorts for Blockchain Technology Consumer Solutions. It originally incorporated in Nevada in 2008 as Hotel Management Systems, Inc. and entered into an Exchange Agreement with BitcoinShop.us, LLC in 2014 formally changing its name to BTCS Inc. in July 2015.

Various summaries of the company found online indicate that the company’s business includes:

  • A cost-effective bitcoin mining services business, focuses on transaction verification
  • A beta e-commerce marketplace for the aforementioned cryptocurrencies
  • A bitcoin wallet based on a relatively well known technology and two-factor authentication for secure storage of bitcoin keys

According to various digital currency news sites and press releases dating back to 2014, BTCS claims to have invested in several technologies and firms including the GoCoin payment platform (which appears to be a solid player in the field), GEM (a Bitcoin API developer which is positioning itself as the go-to blockchain company in the healthcare and supply chain fields providing “bank grade” security) and what looks to have been an aborted attempt to merge with Spondoolies-Tech, Ltd. (a cryptocurrency mining equipment vendor) in 2015. Spondoolies shuttered operations in 2016 due to internal problems including inability to meet payroll.

For more info use link below :

https://www.otcmarkets.com/stock/BTCS/quote

Recent News and Trading:

Other recent occurrences include a default on a lease with CSC Leasing Company of numerous servers and power supplies resulting in the forfeiture of a $25,000 security deposit and, of course, the return of all of the equipment to CSC. At this point it is not clear whether this represents a drawback in BTCS’ ability to process e-commerce transactions or whether the capacity lost with the defaulted lease was made up for in other ways.

A visit to the website (shop.btcs.com) reveals a relatively random catalog of consumer items ostensibly available for purchase, but it appears that the bulk of products represented are merely placeholders, perhaps served up by external scrapers or scripts. In limited research, we were unable to find any items actually “in-stock” or “available” for purchase.

All time high was $1.37 per share in early February, 2014 with quite a fall off very shortly thereafter and a settling in at zero from June 1, 2016 to January of 2017, with a recent high of $0.18 in March, 2017. We’re seeing a lot of fluctuation within the $0.07 and $0.08 range over the past few days and since January of this year, daily volume has fluctuated from 120,000 all the way up to 30,000,000 and back down again, with volume for today at 3,389,582 at a closing price of $0.07. There was a 1/60 stock split in February of 2017.

Market Cap 3.06M
Beta 2.88
PE Ratio (TTM) -0.01
EPS (TTM) -5.22

 

 

* Financial statements are incomplete and/or not up-to-date. We could not run down Income Statement, Balance Sheet or Cash Flows for 2017.

Conclusion:

Cryptocurrencies, including Bitcoin, are almost certainly here to stay. Even as the central banks may be attempting to subvert these alternative currencies, the technology behind the blockchain is solid and there is a wide community of developers and entrepreneurs pushing the boundaries and penetrating new sectors of the traditional online economy. There will likely continue to be hacks and breaches such as the $460M disaster that struck Mt. Gox in 2014, partially leading to a temporary decline in Bitcoin’s value, but the technology is simply too firmly entrenched and it stands to reason that security will improve. BTCS was a relative “mover and shaker” in the bitcoin/cryptocurrency world just three short years ago, but with a dearth of recent information to go on, the fact that their flagship website does not appear to be functioning yet (granted, it bears the “beta” designator) and the fact that filings are not up to date or complete may indicate this is one to view with careful scrutiny.

read more

SRUP Makes Gains Of 20% Since Our Alert 2 Days Ago

Jun 12, 2017

OUR NEW PROFILE IS: SRUP

Worldwide cybersecurity market grew from $3.5 billion in 2004 to $75 billion in 2015, forecasted to reach $170 billion by 2020.

We are all living in the age of never before seen cybercriminal activity, so large in fact that it is nearly impossible to accurately track.

Good Evening Everyone,

We told you that we have something tremendous for tomorrow’s session.
This one has the potential to be our biggest play to date.
Turn your attention to SRUP.
This one looks amazing from a  technical standpoint.  Back in late January it ran all the way up to .82 from .25 on heavy volume.
Since then SRUP sold off on very light volume all the way back to .05 where it found a bottom and has been moving north on just a little bit of interest.
Last week we saw a little action out of nowhere and SRUP took off to .13 in a hurry but quickly tailed off when that action stopped.
We think that we are timing this one perfect with a  lot of action to follow this week.
 
SRUP is not something you want to sleep on.
They are tackling a major problem right now.  We are seeing cyber attacks in the news almost on a daily basis.  These cyber terrorists have the ability to do some real damage as we have seen in the past.  Just ask Sony.

THE MARKET

The global cybersecurity market has grown approximately 35 times over the past 13 years. It is predicted to continue growing over the time to come and reach a staggering $170 billion by 2020.“Cybersecurity is the fastest growing tech sector. One of the main reasons for this is that all other sectors are fighting inefficiencies and striving for optimisation of everything whereas cybersecurity is driven mainly by cybercrime.

WannaCry ransomware attack?

Let us provide some background about the WannaCry ransomware attack, which impacted the entire world. On May 12, 2017, some big organizations, such as Britain’s National Health Service, FedEx, and Deutsche Bahn, reported that a large number of computers had been attacked by a virus that had encrypted the information stored. Hackers demanded $300 to $600 from each user to recover the encrypted files. This was the photo that the user could see and also the payment window:

 

The virus attacked windows systems that had not been updated and did not include a “critical” patch that had been “issued by Microsoft on 14 March 2017 to remove an underlying vulnerability “. Many organizations, which were not secured, suffered the attack that spread all over the world in the following days. Experts estimate that over 200,000 victims and more than 230,00 computers were infected. The virus did not slow down its activity until approximately May 19.

 

 

Let’s focus on the market now. According to Forbes, the market priced the attack by pushing up cybersecurity companies:

“Companies that saw their stocks jump the most following the hacks though were Mimecast(11%), Sophos Group (7.8%), Proofpoint(7.3%), and Fireeye (7%)” Source

We went to check for example the Sophos share price reaction:

 

 

Connectivity comes at a price

There is a good chance that by 2020 healthcare products that are connected to the internet will be worth over 285 billion in economic value

Medical device cybersecurity is a major issue today as security breaches become more sophisticated and common, costing healthcare businesses more and more money. In order to protect the industry medical devices, equipment and data has to be protected, to do so we believe preemptive actions are required.

Sirrus Corp – Your Security Navigation Partner

Sirrus Corp was founded to assist clients and partners with navigating the exceedingly complex issues of corporate security through comprehensive penetration testing and network scanning, followed by design and implementation, utilizing their proprietary products and services.

Sirrus Corp provides tangible, provable network protection that keeps companies in compliance with privacy and HIPPA regulations for data storage and management in real time.

Internal and external, automated scanning maintains compliance via proprietary digital marking, tracking and archiving, all customized for each company’s needs.

Security Solutions

Sirrus Corp has developed their security solutions to be unintimidating, reasonably priced and most are offered as fully managed services including real-time monitoring with regularly scheduled security scans to ensure the integrity of their client’s security protocols.

LightsOut

LightsOut sends notification of location breach, outages and includes a monthly monitoring fee, which becomes a recurring revenue stream for the product line.

LightsOut portable all in one hardware device, which consists of a core technology based on the miniature Arduino platform, includes motion sensors, smoke detectors, access control and it can run up to 45 days on battery power alone. These tiny systems notify the system administrator of any preprogrammed alert via cell, email or text.

  • A physical security solution
  • Especially beneficial to consumers and businesses that do not have access to power or Internet, or wish to know if they lose power or Internet at a specific location.
  • Data center equipment
  • Field installations
  • Unmanned Locations
  • High-end asset owners
  • Rental properties

TrustLock and MedLock

Network Scanning Devices

These devices reside inside the client’s network and perform preprogrammed network scans, then store and forward log files for future verification of designated events. They can also detect wireless and other unauthorized network access and they are can provide verifiable time stamping when paired with the Sirrus Time Zone device. The Medlock device is pre programmed before installation to address requirements medical related businesses must maintain to remain HIPPA compliant.

These devices are also utilized outside client’s networks by MSP’s to provide scheduled external scanning and breach detection from the Sirrus data center. This external service is offered as a managed service and includes written reports on levels of security maintained or severity of breach should one be detected.

Talk Soon,

The Small Cap Exclusive Team

 

Disclaimer

This email is an advertisement and is provided for information purposes only; it should not be used as the basis for any investment decision. JBN Partners, LLC has been compensated up to $10,000 by a third party (Archangel Media Consulting, LLC) for an awareness campaign regarding SRUP. JBN Partners, LLC and its principals currently hold no shares in SRUP. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. JBN Partners, LLC or its principals may buy or sell securities in the company profiled at any time without notice. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide any advice. The information contained in this email should be viewed as commercial advertisement and is not intended to be advice. This email is not provided to any particular individual with a view toward their individual circumstances. The information contained in this email is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them. This email has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies’ profiled based solely on information contained in this email.  Individuals should assume that all information contained in this email about profiled companies is not trustworthy unless verified by their own independent research. Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own companies and consult with a registered advisor or licensed stock broker before investing. This email is a service of JBN Partners, LLC, a financial marketing and investor relations firm that has been compensated. All direct and third party compensation received has been disclosed within each individual profile in accordance with section 17(b) of the Securities Act of 1933. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. JBN Partners, LLC, and/or its affiliates will hold, buy, and sell securities in the companies profiled. This constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. Information contained in this email will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in this email, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read the information available at the websites of the SEC at www.sec.gov and the Financial Industry Regulatory Authority (“FINRA”) at www.finra.org.

read more

Here’s Who Just Picked Up Photomedex Inc (NASDAQ:PHMD) Shares

May 1, 2017

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Photomedex Inc (NASDAQ:PHMD) reported that Pell Lewis C has picked up 424,064 of common stock as of 2017-05-01.

The acquisition brings the aggregate amount owned by Pell Lewis C to a total of 424,064 representing less than 9.7% stake in the company.

For those not familiar with the company, PhotoMedex, Inc. is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage. The Company operates through three business segments: Consumer segment, Physician Recurring segment and Professional segment. The Company provides skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. The Company’s Consumer segment is engaged in the designing, development, manufacturing and selling of long-term hair reduction and acne consumer products. Its Physician Recurring segment is engaged in the sales of skincare products. Its Professional segment is engaged in the sale of equipment, such as medical and esthetic light and heat based products. Its LHE brands includes Mistral, Kona, FSD, SpaTouch Elite and accessories.

A glance at Photomedex Inc (NASDAQ:PHMD)’s key stats reveals a current market capitalization of 5.27 Million based on 4.36 Million shares outstanding and a price at last close of $1.26 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2012-06-14, Melumad picked up 1,000 at a purchase price of $10.57. This brings their total holding to 8,000 as of the date of the filing.

On the sell side, the most recent transaction saw Connelly unload 1,704 shares at a sale price of $2.61. This brings their total holding to 1,435.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Photomedex Inc (NASDAQ:PHMD) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

read more

International Isotopes Inc. (OTCBB:INIS) is Attracting Smart Money

May 1, 2017

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), International Isotopes Inc. (OTCBB:INIS) reported that Kennerman Associates, Inc. has picked up 195,304,771 of common stock as of 2017-05-01.

The acquisition brings the aggregate amount owned by Kennerman Associates, Inc. to a total of 195,304,771 representing less than 43.3% stake in the company.

For those not familiar with the company, International Isotopes Inc. is a manufacturer of nuclear medicine calibration and reference standards, a range of products, including cobalt teletherapy sources, and a selection of radioisotopes and radiochemicals for medical research and clinical devices. Its segments include Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, Radiological Services and Transportation. The Nuclear Medicine Standards segment manufactures sources and standards associated with Single Photon Emission Computed Tomography (SPECT) imaging, patient positioning and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Cobalt Products include the production of bulk cobalt (cobalt-60), fabrication of cobalt capsules for radiation therapy or various industrial applications, and recycling of expended cobalt sources. Radiochemical Products include production and distribution of various isotopically pure radiochemicals.

A glance at International Isotopes Inc. (OTCBB:INIS)’s key stats reveals a current market capitalization of 28.49 Million based on 406.96 Million shares outstanding and a price at last close of $0.07 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2015-03-06, Grosso picked up 1,766,667 at a purchase price of $0.02. This brings their total holding to 19,845,926 as of the date of the filing.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on International Isotopes Inc.  (OTCBB:INIS) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

read more

Baird Brent D Picked Rand Logistics Inc. (NASDAQ:RLOG) Shares

May 1, 2017

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Rand Logistics Inc. (NASDAQ:RLOG) reported that Baird Brent D has picked up 1,600,000 of common stock as of 2017-05-01.

The acquisition brings the aggregate amount owned by Baird Brent D to a total of 1,600,000 representing less than 8.59% stake in the company.

For those not familiar with the company, Rand Logistics, Inc. is a shipping company that, through its operating subsidiaries, is engaged in the operation of bulk carriers on the Great Lakes. The Company’s shipping business is operated in Canada by Lower Lakes Towing Ltd. (Lower Lakes Towing) and in the United States by Lower Lakes Transportation Company (Lower Lakes Transportation). The Company transports construction aggregates, salt, grain, coal, iron ore, and other dry bulk commodities for customers in the construction, electric utility, food, and integrated steel industries. Lower Lakes’ fleet consists of approximately six self-unloading bulk carriers and over four conventional bulk carriers in Canada and approximately six self-unloading bulk carriers in the United States, including over three articulated tug and barge units. Lower Lakes Towing owns approximately nine Canadian vessels and Lower Lakes Towing (17) Ltd. (Lower Lakes (17)) owns the tenth Canadian vessel.

A glance at Rand Logistics Inc. (NASDAQ:RLOG)’s key stats reveals a current market capitalization of 13.62 Million based on 18.62 Million shares outstanding and a price at last close of $0.720 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-03-11, Levy picked up 1,500 at a purchase price of $1.04. This brings their total holding to 470,674 as of the date of the filing.

On the sell side, the most recent transaction saw Knott unload 18,013 shares at a sale price of 0.86. This brings their total holding to 260,135.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Rand Logistics Inc. (NASDAQ:RLOG) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

read more
Guess Who Picked Onconova Therapeutics Inc. (NASDAQ:ONTX) Shares

Guess Who Picked Onconova Therapeutics Inc. (NASDAQ:ONTX) Shares

May 1, 2017

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Onconova Therapeutics Inc. (NASDAQ:ONTX) reported that Sabby Capital has picked up 702,896 of common stock as of 2017-05-01.

The acquisition brings the aggregate amount owned by Sabby Capital to a total of 702,896 representing less than 7.61% stake in the company.

For those not familiar with the company, Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The Company’s lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.

A glance at Onconova Therapeutics Inc. (NASDAQ:ONTX) key stats reveals a current market capitalization of 22.72 Million based on 9.24 Million shares outstanding and a price at last close of $2.35 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2017-04-26, Bienen picked up 3,810 at a purchase price of $2.10. This brings their total holding to 12,724 as of the date of the filing.

On the sell side, the most recent transaction saw Kumar unload 20,000 shares at a sale price of 15.11. This brings their total holding to 276,500.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Onconova Therapeutics Inc. (NASDAQ:ONTX) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

read more

Here’s Who Just Picked Up TrueCar Inc. (NASDAQ:TRUE) Shares

May 1, 2017

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), TrueCar Inc. (NASDAQ:TRUE) reported that Caledonia (private) Investments Pty Ltd has picked up 8,651,911 of common stock as of 2017-05-01.

The acquisition brings the aggregate amount owned by Caledonia (private) Investments Pty Ltd to a total of 8,651,911 representing less than 9.93% stake in the company.

For those not familiar with the company, TrueCar, Inc. is an Internet-based information, technology, and communication services company. The Company has a data-driven online platform, which features market data and analytics. The Company-branded platform is available on its TrueCar Website and mobile applications. It customizes and operates its platform on a co-branded basis for its affinity group marketing partners, including financial institutions, membership-based organizations, and employee buying programs for a range of enterprises. The Company enables users to obtain market-based pricing data on new and used cars, and to connect with its network of TrueCar Certified Dealers. Its network of over 13,000 TrueCar Certified Dealers consists primarily of new car franchises, as well as independent dealers selling used vehicles. Its subsidiary, ALG, Inc., provides forecasts and consulting services regarding determination of the residual value of an automobile at given future points in time.

A glance at TrueCar Inc. (NASDAQ:TRUE)’s key stats reveals a current market capitalization of 1.57 Billion based on 89.10 Million shares outstanding and a price at last close of $17.72 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-03-09, Claus picked up 5,000 at a purchase price of $5.70. This brings their total holding to 80,000 as of the date of the filing.

On the sell side, the most recent transaction saw Gunsagar unload 25,571 shares at a sale price of $14.70. This brings their total holding to 315,181.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on TrueCar Inc. (NASDAQ:TRUE) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

read more
Arena Pharmaceuticals Inc (NASDAQ:ARNA) is Attracting Smart Money

Arena Pharmaceuticals Inc (NASDAQ:ARNA) is Attracting Smart Money

Apr 28, 2017

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Arena Pharmaceuticals Inc (NASDAQ:ARNA) reported that Great Point Partners has picked up 30,000,000 of common stock as of 2017-04-28.

The acquisition brings the aggregate amount owned by Great Point Partners to a total of 30,000,000 representing less than 9.75% stake in the company.

For those not familiar with the company, Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering Phase II evaluation for the treatment of pain associated with Crohn’s disease, and ralinepag (APD811) in Phase II evaluation for pulmonary arterial hypertension (PAH). The Company’s drug, Lorcaserin, is approved for marketing in the United States and South Korea for the indication of weight management. The Company’s drug candidates in clinical development include APD334 for autoimmune diseases, ralinepag for vascular diseases and APD371 for pain. The Company’s programs under collaboration include nelotanserin for dementia-associated psychosis, temanogrel for thrombotic diseases, and an undisclosed orphan GPCR for central nervous system (CNS) indication(s).

A glance at Arena Pharmaceuticals Inc (NASDAQ:ARNA)’s key stats reveals a current market capitalization of 409.39 Million based on 307.73 Million shares outstanding and a price at last close of $1.34 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2017-04-26, Munshi picked up 50,000 at a purchase price of $1.41. This brings their total holding to 51,875 as of the date of the filing.

On the sell side, the most recent transaction saw White unload 18,728 shares at a sale price of $1.99. This brings their total holding to 85,529.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Arena Pharmaceuticals Inc (NASDAQ:ARNA) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

read more

Guess Who Picked Castlight Health Inc. (NYSE:CSLT) Shares

Apr 28, 2017

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Castlight Health Inc. (NYSE:CSLT)reported that Sap Se has picked up 4,762,658 of common stock as of 2017-04-28.

The acquisition brings the aggregate amount owned by Sap Se to a total of 4,762,658 representing less than 9.3% stake in the company.

For those not familiar with the company, Castlight Health, Inc. offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent. Its products deliver employee engagement and enable employers to integrate benefit programs into a single platform available to employees and their families. Its health benefits platform engages external data and its substantial user base to provide a single, end-to-end solution that engages employees through personalized and relevant communications. Its offering provides employers the opportunity to communicate, measure, and get value out of their benefits and programs on a real-time basis. It offers cross-sell products, such as Castlight Action, Castlight Pharmacy, Castlight Dental, Castlight Elevate, Castlight Protect and Castlight Rewards.

A glance at Castlight Health Inc. (NYSE:CSLT)’s key stats reveals a current market capitalization of 391.10 Million based on 50.02 Million shares outstanding and a price at last close of $3.85 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2015-11-18, Roberts picked up 121,300 at a purchase price of $3.85. This brings their total holding to 1,256,730 as of the date of the filing.

On the sell side, the most recent transaction saw Nolan unload 270 shares at a sale price of $3.45. This brings their total holding to 33,149.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Castlight Health Inc. (NYSE:CSLT) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

read more